Kidney patients needed for safety study of experimental liver drug
NCT ID NCT07262333
First seen Dec 16, 2025 · Last updated May 16, 2026 · Updated 17 times
Summary
This study tests a single dose of hydroxynidone, an experimental drug for liver scarring, in 56 adults with mild to severe kidney problems and healthy volunteers. Researchers want to see how the drug moves through the body and if it is safe when kidneys are not working well. The results will help doctors decide the right dose for patients with kidney issues.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL INSUFFICIENCY CHRONIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology
RECRUITINGHubei, Wuhan, China
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.